- Home
- NXL vs HSCS Comparison
NXL vs HSCS Comparison
Compare NXL & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXL | HSCS |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United States |
| Employees | 8 | 12 |
| Industry | Medical Specialities | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 6.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NXL | HSCS |
|---|---|---|
| Price | $0.36 | $1.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 125.6K | 18.6K |
| Earning Date | 05-11-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $15.52 | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.31 | $1.77 |
| 52 Week High | $2.00 | $6.47 |
Technical Indicators
Market Signals| Indicator | NXL | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 50.40 | 46.76 |
| Support Level | $0.37 | $1.85 |
| Resistance Level | $0.46 | $2.16 |
| Average True Range (ATR) | 0.02 | 0.13 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 74.19 | 54.56 |
Price Performance
Historical ComparisonAbout NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.